A Critical Appraisal of Once-daily Topical Luliconazole for the Treatment of Superficial Fungal Infections

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2016 Feb 6

PMID 26848272

Citations 12

Authors

Aditya K Gupta

Deanne Daigle

Affiliations

Soon will be listed here.

Abstract

Luliconazole is a novel imidazole derivative, which has demonstrated in vitro efficacy against dermatophytes and Candida. The results from Phase III trials show that luliconazole 1% cream applied once daily for 2 weeks successfully resolved the clinical signs and symptoms as well as eradicated the pathologic fungi, which cause tinea pedis. A 1-week treatment with luliconazole 1% cream also produced favorable clinical and mycological results in clinical trials for tinea corporis and tinea cruris. Across trials, adverse events consisted mainly of localized reactions following application. The development of a new antifungal agent is timely due to mounting resistance among existing treatments. Because luliconazole requires a short duration of treatment, it may assist in reducing disease recurrence as a result of patient nonadherence.

Citing Articles

The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies.

Zobi C, Algul O Chem Biol Drug Des. 2025; 105(1):e70045.

PMID: 39841631 PMC: 11753615. DOI: 10.1111/cbdd.70045.

Refractory Fungal Keratitis Caused by Acrophialophora fusispora: A Case Report and Literature Review.

Fukuto A, Chikama T, Ota S, Yaguchi T, Kiuchi Y Cureus. 2023; 15(8):e43181.

PMID: 37692748 PMC: 10485727. DOI: 10.7759/cureus.43181.

Tinea pedis: an updated review.

Leung A, Barankin B, Lam J, Leong K, Hon K Drugs Context. 2023; 12.

PMID: 37415917 PMC: 10321471. DOI: 10.7573/dic.2023-5-1.

Tinea Gladiatorum: Epidemiology, Clinical Aspects, and Management.

Zalewski A, Goldust M, Szepietowski J J Clin Med. 2022; 11(14).

PMID: 35887830 PMC: 9315553. DOI: 10.3390/jcm11144066.

Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study.

Dakhale G, Gupta A, Mukhi J, Kalikar M Perspect Clin Res. 2021; 12(4):223-228.

PMID: 34760651 PMC: 8525790. DOI: 10.4103/picr.PICR_24_19.

References

Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A . Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. J Drugs Dermatol. 2014; 13(7):838-46. View

Koga H, Nanjoh Y, Makimura K, Tsuboi R . In vitro antifungal activities of luliconazole, a new topical imidazole. Med Mycol. 2008; 47(6):640-7. DOI: 10.1080/13693780802541518. View

McClellan K, Wiseman L, Markham A . Terbinafine. An update of its use in superficial mycoses. Drugs. 1999; 58(1):179-202. DOI: 10.2165/00003495-199958010-00018. View

Ilkit M, Durdu M . Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2014; 41(3):374-88. DOI: 10.3109/1040841X.2013.856853. View

Koga H, Tsuji Y, Inoue K, Kanai K, Majima T, Kasai T . In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J Infect Chemother. 2006; 12(3):163-5. DOI: 10.1007/s10156-006-0440-4. View

Routt E, Jim S, Zeichner J, Kircik L . What is new in fungal pharmacotherapeutics?. J Drugs Dermatol. 2014; 13(4):391-5. View

Koga H, Nanjoh Y, Kaneda H, Yamaguchi H, Tsuboi R . Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Antimicrob Agents Chemother. 2012; 56(6):3138-43. PMC: 3370799. DOI: 10.1128/AAC.05255-11. View

Havlickova B, Czaika V, Friedrich M . Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51 Suppl 4:2-15. DOI: 10.1111/j.1439-0507.2008.01606.x. View

Niwano Y, Kuzuhara N, Kodama H, Yoshida M, Miyazaki T, Yamaguchi H . In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Antimicrob Agents Chemother. 1998; 42(4):967-70. PMC: 105583. DOI: 10.1128/AAC.42.4.967. View

10.

Jarratt M, Jones T, Kempers S, Rich P, Morton K, Nakamura N . Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study. Cutis. 2013; 91(4):203-10. View

11.

Gupta A, Sauder D, Shear N . Antifungal agents: an overview. Part I. J Am Acad Dermatol. 1994; 30(5 Pt 1):677-98; quiz 698-700. View

12.

Jerajani H, Janaki C, Kumar S, Phiske M . Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study. Indian J Dermatol. 2013; 58(1):34-8. PMC: 3555370. DOI: 10.4103/0019-5154.105284. View

13.

Moriarty B, Hay R, Morris-Jones R . The diagnosis and management of tinea. BMJ. 2012; 345:e4380. DOI: 10.1136/bmj.e4380. View

14.

Borgers M . Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis. 1980; 2(4):520-34. DOI: 10.1093/clinids/2.4.520. View

15.

Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K . Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study. Mycoses. 2007; 50(1):35-40. DOI: 10.1111/j.1439-0507.2006.01305.x. View

16.

Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K . A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis. Mycoses. 2006; 49(3):236-41. DOI: 10.1111/j.1439-0507.2006.01218.x. View

17.

Jones T, Jarratt M, Mendez-Moguel I, Paz N, Grekin S, Cognata Smith C . A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris. J Drugs Dermatol. 2014; 13(1):32-8. View

18.

Khanna D, Bharti S . Luliconazole for the treatment of fungal infections: an evidence-based review. Core Evid. 2014; 9:113-24. PMC: 4181444. DOI: 10.2147/CE.S49629. View

19.

Hainer B . Dermatophyte infections. Am Fam Physician. 2003; 67(1):101-8. View